top
Search terms
Results 1 - 10 of 12 - ordered by :
Pages: 1 2
Epeuropace

Methods and results The study population consisted of patients with an ejection fraction 40% undergoing ICD implantation (n = 911) for the primary or secondary prevention of sudden cardiac death from ...

Europace, CLINICAL RESEARCH, Sanjeev P. Bhavnani, Anupam Kumar, Craig I. Coleman, Danette Guertin, Ravi K. Yarlagadda, Christopher A. Clyne, Jeffrey Kluger

Date : 01/01/2014 Item size : 271887 bytes
Epeuropace

Abstract Aims To evaluate the incidences of and risk factors predisposing to appropriate and inappropriate shocks and mortality in a real-world population of patients with ischaemic heart disease ...

Europace, CLINICAL RESEARCH, Peter Weeke, Jens Brock Johansen, Ole Dan Jørgensen, Jens Cosedis Nielsen, Mogens Møller, Regitze Videbæk, Michael Vinther Højgaard, Sam Riahi, Peter Karl ...

Date : 01/08/2013 Item size : 269036 bytes
Epeuropace

Introduction The past decade has seen rapid progress in cardiac implantable electronic devices delivering implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy ...

Europace, Editorial, Francisco Leyva, Christopher J. Plummer

Date : 01/03/2015 Item size : 144334 bytes
Epeuropace

CAA may involve an abnormal origin (number, location, size, angle of origination), course (intramural aortic), termination, or structure (fistula) of the coronary arteries.1 Most CAAs are clinically ...

Europace, Short Communication, Petr Parizek, Ludek Haman, Jan Harrer, Miloslav Tauchman, Vladimir Rozsival, Ivo Varvarovsky, Miloslav Pleskot, Miroslav Mestan, Josef Stasek

Date : 01/09/2010 Item size : 143721 bytes
Epeuropace

Abstract Aims The purpose of this study is to investigate compliance to established guidelines regarding primary prevention with implantable cardioverter-defibrillator (ICD) in patients with left ...

Europace, Sudden Death and ICDs, Johanna Sjöblom, Lina Ljung, Mats Frick, Mårten Rosenqvist, Viveka Frykman

Date : 01/04/2012
Epeuropace

Clinicians are commonly faced with patients who have ventricular dysfunction and nonsustained ventricular tachyarrhythmia developing shortly after revascularization. Since there are no ...

Europace, OPINION, Islam Bolad, David T. Martin

Date : 01/01/2005
Epeuropace

Abstract Patients with an implantable cardioverter defibrillator (ICD) implanted for primary prevention have an increased mortality rate if they receive appropriate and/or inappropriate ICD ...

Europace, Review, Cihan Cevik, Alejandro Perez-Verdia, Kenneth Nugent

Date : 01/06/2009
Epeuropace

Abstract Aims Atrial fibrillation (AF) is often present in patients with left ventricular dysfunction who receive an implantable cardioverter-defibrillator (ICD). Conclusion Our study demonstrates ...

Europace, ATRIAL FIBRILLATION, Marcelle D. Smit, Pascal F.H.M. Van Dessel, Michiel Rienstra, Wybe Nieuwland, Ans C.P. Wiesfeld, Eng S. Tan, Rutger L. Anthonio, Dirk J. Van Veldhuisen, Isabelle C. Van ...

Date : 01/08/2006
Epeuropace

Abstract Aims To assess the impact of the new UK National Institute for Health and Clinical Excellence (NICE) guidelines on the incidence of implantable cardioverter defibrillator (ICD) indications ...

Europace, ICD FOR PRIMARY PREVENTION: MORE IMPLANTS ARE NEEDED, P.A. Scott, S. Gorman, N.P. Andrews, P.R. Roberts, P.R. Kalra

Date : 01/04/2008
Epeuropace

Abstract Aims The aims of this study were to describe arrhythmias documented with an implantable loop recorder (ILR) in post-acute myocardial infarction (AMI) patients with left ventricular ...

Europace, CLINICAL RESEARCH, Uffe Jakob Ortved Gang, Christian Jøns, Rikke Mørch Jørgensen, Steen Zabell Abildstrøm, Jens Haarbo, Marc D. Messier, Heikki V. Huikuri, Poul Erik Bloch ...

Date : 01/02/2010